Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-Label, Multiple-Dose Phase II Study to Evaluate Efficacy and Safety of D-0120 Administered in Combination With Allopurinol in Subjects With Gout

NCT05665699 is registered in ClinicalTrials.gov with InventisBio Co., Ltd as lead sponsor.

NCT NCT05665699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05665699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-Label, Multiple-Dose Phase II Study to Evaluate Efficacy and Safety of D-0120 Administered in Combination With Allopurinol in Subjects With Gout
Lead sponsor
InventisBio Co., Ltd
Phase
Phase 2
Overall status
Completed
Start date
April 17, 2023
Completion date
December 30, 2025
Enrollment
80 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

gout